HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of Pim-1 kinase ameliorates dextran sodium sulfate-induced colitis in mice.

AbstractBACKGROUND:
Pim-1 kinase is involved in the control of cell growth, differentiation and apoptosis. Recent evidence suggests that Pim kinases play a role in immune regulation and inflammation. However, the role of Pim-1 kinase in inflammatory bowel diseases (IBD) remains unclear.
AIMS:
The aims of this study were to explore the role of Pim-1 kinase in the pathology of IBD and to assess whether inhibiting Pim-1 kinase may be of therapeutic benefit as a treatment regimen for IBD.
METHODS:
Colitic mouse model was established by the induction of dextran sodium sulfate. The expression of Pim-1 in the colonic samples of control and colitic mice was examined. Furthermore, the mice were treated with Pim-1inhibitor (PIM-Inh), then the body weight and colon inflammation were evaluated, and the production of cytokines including IFN-γ, IL-4, TGF-β and IL-17 in colon tissues was determined by ELISA. The expression of T cell master transcription factors T-bet, ROR-γt, GATA-3 and Foxp3 and Nuclear factor κB (NF-κB) and inducible nitric oxide synthase in colon tissues was detected by real-time PCR and western blot. Finally, the effect of LPS on Pim-1 expression and the effects of PIM-Inh on LPS-induced upregualtion of p65 and TNF-α in RAW264.7 cells were examined by real-time PCR and western blot.
RESULTS:
Pim-1 expression was correlated with the degree of mucosal inflammation in vivo, and it was significantly induced by LPS in vitro. PIM-Inh had protective effects on acute colitis in vivo. Mechanistically, PIM-Inh reduced the proinflammatory immune response through the inhibition of the overactivation of macrophages and the down-regulation of excessive Th1- and Th17-type immune responses. Furthermore, PIM-Inh could skew T cell differentiation towards a Treg phenotype.
CONCLUSIONS:
Pim-1 kinase is involved in mucosal injury/inflammation and Pim-1 kinase inhibitor may provide a novel therapeutic approach for IBD.
AuthorsYue-Ming Shen, Yan Zhao, Ya Zeng, Lu Yan, Bo-Lin Chen, Ai-Min Leng, Yi-Bin Mu, Gui-Ying Zhang
JournalDigestive diseases and sciences (Dig Dis Sci) Vol. 57 Issue 7 Pg. 1822-31 (Jul 2012) ISSN: 1573-2568 [Electronic] United States
PMID22466098 (Publication Type: Journal Article)
Chemical References
  • Cytokines
  • Enzyme Inhibitors
  • Lipopolysaccharides
  • Transcription Factors
  • Tumor Necrosis Factor-alpha
  • Dextran Sulfate
  • Proto-Oncogene Proteins c-pim-1
  • eIF-2 Kinase
Topics
  • Animals
  • Cells, Cultured
  • Colitis (chemically induced, metabolism, prevention & control)
  • Colon (drug effects, metabolism, pathology)
  • Cytokines (metabolism)
  • Dextran Sulfate (adverse effects)
  • Disease Models, Animal
  • Enzyme Inhibitors (pharmacology, therapeutic use)
  • In Vitro Techniques
  • Lipopolysaccharides (pharmacology)
  • Macrophages (drug effects, metabolism, pathology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Proto-Oncogene Proteins c-pim-1 (antagonists & inhibitors, drug effects, metabolism)
  • Transcription Factors (metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Up-Regulation (drug effects)
  • eIF-2 Kinase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: